In 2016, Dr. Ross was invited by world-renowned neuroscientist Dr. Dale Bredesen, MD, to join his team at MPI Cognition as the founding Chief Medical Officer. Together, Dr. Ross and Dr. Bredesen were able to develop timodal therapy to treat Alzheimer’s disease patients designed to halt the progression of the disease and, in some cases, and apply a mul reverse the disease. In August 2018, Dr. Bredesen sold his company, and Dr. Ross opted not to join the new organization.
Dr. Leroy Hood, MD, one of the world’s top scientists (inventor of the human genome sequencer and recipient of The National Medal of Science awarded by President Obama), invited Dr. Ross to come to Seattle, WA, to open the Brain Health & Research Institute. BH&RI would partner with Dr. Hood’s Institute for Systems Biology (ISB) to look for underlying clues leading to a better solution and potential cure for Alzheimer’s. This partnership represented a unique union of science and clinical medicine. Working together, they hoped to identify and correct drivers of brain disease and impact the global burden of brain illnesses.
Dr. Ross and her team moved to Seattle, WA. Things were going well until COVID-19 hit, stopping the ability to see patients in person. Before COVID, patients flew into Seattle for a two-day evaluation by the team of experts at BHRI. Once the evaluation was completed, the patients were given a personalized program they would follow for one year. Dr. Ross’s team of health coaches, dieticians, physical therapists, and neuropsychologists helped implement and follow all patients remotely.
Post-COVID, Dr. Ross and the team have artfully taken the entire program online. They have developed small group educational classes that meet biweekly and cover topics surrounding the multimodal program, including diet/nutrition, mindfulness, brain exercises, sleep, and brain-centric physical exercise taught by the physical therapists. All patients also undergo individual pillars of the coaching and PT meetings one-on-one via Zoom. BHRI is now a coaching and patient education company.